Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Changes in Shareholders' Equity

v3.24.2
Consolidated Statement of Changes in Shareholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Preferred Stock
Common Stock and Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2022 $ 273,197 $ 184 $ 28,397 $ 58,953 $ 207,003 $ 184 $ (21,156)
Beginning balance (in shares) at Dec. 31, 2022       7,996.8      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 15,569       15,569    
Net change in debt securities 723           723
Net change in debit valuation adjustments (394)           (394)
Net change in derivatives 49           49
Employee benefit plan adjustments 19           19
Net change in foreign currency translation adjustments 17           17
Dividends declared:              
Common (3,541)       (3,541)    
Preferred (811)       (811)    
Common stock issued under employee plans, net, and other 1,072     $ 1,079 (7)    
Common stock issued under employee plans, net, and other (in shares)       42.8      
Common stock repurchased (2,765)     $ (2,765)      
Common stock repurchased (in shares)       (86.0)      
Ending balance at Jun. 30, 2023 283,319   28,397 $ 57,267 218,397   (20,742)
Ending balance (in shares) at Jun. 30, 2023       7,953.6      
Beginning balance at Mar. 31, 2023 280,196   28,397 $ 57,264 213,062   (18,527)
Beginning balance (in shares) at Mar. 31, 2023       7,972.4      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 7,408       7,408    
Net change in debt securities 168           168
Net change in debit valuation adjustments (404)           (404)
Net change in derivatives (1,993)           (1,993)
Employee benefit plan adjustments 9           9
Net change in foreign currency translation adjustments 5           5
Dividends declared:              
Common (1,767)       (1,767)    
Preferred (306)       (306)    
Common stock issued under employee plans, net, and other 553     $ 553      
Common stock issued under employee plans, net, and other (in shares)       0.4      
Common stock repurchased (550)     $ (550)      
Common stock repurchased (in shares)       (19.2)      
Ending balance at Jun. 30, 2023 283,319   28,397 $ 57,267 218,397   (20,742)
Ending balance (in shares) at Jun. 30, 2023       7,953.6      
Beginning balance at Dec. 31, 2023 291,646   28,397 $ 56,365 224,672   (17,788)
Beginning balance (in shares) at Dec. 31, 2023       7,895.5      
Dividends declared:              
Preferred (532)            
Ending balance at Mar. 31, 2024 293,552   28,397 $ 54,310 228,902   (18,057)
Ending balance (in shares) at Mar. 31, 2024       7,866.9      
Beginning balance at Dec. 31, 2023 291,646   28,397 $ 56,365 224,672   (17,788)
Beginning balance (in shares) at Dec. 31, 2023       7,895.5      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 13,571       13,571    
Net change in debt securities 27           27
Net change in debit valuation adjustments (135)           (135)
Net change in derivatives 270           270
Employee benefit plan adjustments 48           48
Net change in foreign currency translation adjustments (51)           (51)
Dividends declared:              
Common (3,797)       (3,797)    
Preferred (842)       (842)    
Redemption of preferred stock (1,854)   (1,849)   (5)    
Common stock issued under employee plans, net, and other 1,044     $ 1,046 (2)    
Common stock issued under employee plans, net, and other (in shares)       44.4      
Common stock repurchased (6,035)     $ (6,035)      
Common stock repurchased (in shares)       (165.1)      
Ending balance at Jun. 30, 2024 293,892   26,548 $ 51,376 233,597   (17,629)
Ending balance (in shares) at Jun. 30, 2024       7,774.8      
Beginning balance at Mar. 31, 2024 293,552   28,397 $ 54,310 228,902   (18,057)
Beginning balance (in shares) at Mar. 31, 2024       7,866.9      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 6,897       6,897    
Net change in debt securities (305)           (305)
Net change in debit valuation adjustments 53           53
Net change in derivatives 686           686
Employee benefit plan adjustments 25           25
Net change in foreign currency translation adjustments (31)           (31)
Dividends declared:              
Common (1,887)       (1,887)    
Preferred (310)       (310)    
Redemption of preferred stock (1,854)   (1,849)   (5)    
Common stock issued under employee plans, net, and other 601     $ 601      
Common stock issued under employee plans, net, and other (in shares)       0.4      
Common stock repurchased (3,535)     $ (3,535)      
Common stock repurchased (in shares)       (92.5)      
Ending balance at Jun. 30, 2024 $ 293,892   $ 26,548 $ 51,376 $ 233,597   $ (17,629)
Ending balance (in shares) at Jun. 30, 2024       7,774.8